We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

V:NYSEVisa Inc. Analysis

Data as of 2026-03-09 - not real-time

$314.37

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Visa (V) continues to post exceptional profitability, with a 14.6% YoY revenue growth and a 97.8% gross margin that translates into a 68.3% operating margin and a 50.2% net profit margin. Return on equity sits at an impressive 53.9% while cash generation remains robust, reflected in $22.0 B of free cash flow. The stock trades at a forward PE of 21.6 versus a trailing PE of 29.5, both well above the industry average PE of 17.2, suggesting the market is pricing in significant growth expectations. Recent fiscal Q1 results beat forecasts, with revenue up 15% YoY to $10.9 B, prompting upgrades from analysts and a median price target of $402.8, indicating upside potential of roughly 27% from the current $314.37 price.
Technically, the price sits below the 20‑day (≈$319), 50‑day (≈$330) and 200‑day (≈$342) moving averages, confirming a short‑term bearish bias, while the RSI of 41 hints at a modestly oversold condition. The MACD histogram is positive and the line sits above the signal, offering a subtle bullish divergence, but volume is decreasing and 30‑day volatility remains high at 26%, underscoring near‑term risk. Despite a modest 0.84% dividend yield, the payout ratio of 23% and strong cash flow support dividend sustainability, making the stock a resilient income play for long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish momentum
  • Decreasing volume and elevated 30‑day volatility
  • Strong earnings beat and low payout ratio supporting fundamentals

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 14.6% and expanding margins
  • Analyst upgrades and median target price of $402.8
  • Robust cash flow and high ROE suggesting durable profitability

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Global payment network with high barriers to entry
  • Sustainable dividend supported by strong free cash flow
  • Consistently high operating leverage and low beta relative to market

Key Metrics & Analysis

Financial Health

Revenue Growth14.60%
Profit Margin50.23%
P/E Ratio29.5
ROE53.95%
ROA18.36%
Debt/Equity54.61
P/B Ratio15.7
Op. Cash Flow$24.4B
Free Cash Flow$22.0B
Industry P/E17.2

Technical Analysis

TrendBearish
RSI41.1
Support$303.08
Resistance$332.82
MA 20$318.89
MA 50$330.21
MA 200$341.83
MACDBullish
VolumeDecreasing
Fear & Greed Index100

Valuation

Fair Value$289.45
Target Price$400.47
Upside/Downside27.39%
GradeOvervalued
TypeBlend
Dividend Yield0.84%

Risk Assessment

Beta0.78
Volatility26.02%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.